The medical device is misbranded in that the compliance chart of the Stent diameter may allow overexpansion that may result in vessel damage.
Source facts
Action
On 7/21/03, the firm issued letters via Federal Express to all its direct consignees, informing them of the affected devices and providing instructions on the recall.
Initiated
2003-07-21
Root cause
Other
Terminated
2003-08-20
Distribution
Product received nationwide distribution to approx. 38 direct consignees. The recall was appropriately extended to the user level; i.e., the hospital/medical centers, physicians who received the recalled product.
There is no known Canadian distribution.
Recall number
Z-1141-03
Recall status
Terminated
CDRH record ID
28567
FDA classified
2003-08-20
Recall event number
26854
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.